BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10030433)

  • 1. Lamotrigine in the treatment of epilepsy in people with intellectual disability.
    Besag FM
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():50-6. PubMed ID: 10030433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.
    Alvarez N; Besag F; Iivanainen M
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():1-15. PubMed ID: 10030426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of adjunctive lamotrigine for refractory epilepsy in institutional or community residents with mental retardation.
    Sunder TR; McKee JR; Hammer AE; Vuongc A
    Curr Med Res Opin; 2006 Apr; 22(4):693-702. PubMed ID: 16684430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiepileptic drugs with mood stabilizing properties and their relation with psychotropic drug use in institutionalized epilepsy patients with intellectual disability.
    Leunissen CL; de la Parra NM; Tan IY; Rentmeester TW; Vader CI; Veendrick-Meekes MJ; Aldenkamp AP
    Res Dev Disabil; 2011; 32(6):2660-8. PubMed ID: 21752594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: a retrospective evaluation.
    Gidal BE; Walker JK; Lott RS; Shaw R; Speth J; Marty KJ; Rutecki P
    Seizure; 2000 Mar; 9(2):131-6. PubMed ID: 10845738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy.
    Fakhoury TA; Hammer AE; Vuong A; Messenheimer JA
    Epilepsy Behav; 2004 Aug; 5(4):532-8. PubMed ID: 15256191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxcarbazepine in the treatment of epilepsy in children and adolescents with intellectual disability.
    Gaily E; Granström ML; Liukkonen E
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():41-5. PubMed ID: 10030431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproate in the treatment of epilepsy in people with intellectual disability.
    Friis ML
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():32-5. PubMed ID: 10030429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical efficacy of lamotrigine as an antiepileptic drug.
    Pellock JM
    Neurology; 1994 Nov; 44(11 Suppl 8):S29-35. PubMed ID: 7970004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits.
    Uvebrant P; Bauzienè R
    Neuropediatrics; 1994 Dec; 25(6):284-9. PubMed ID: 7770124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group.
    Motte J; Trevathan E; Arvidsson JF; Barrera MN; Mullens EL; Manasco P
    N Engl J Med; 1997 Dec; 337(25):1807-12. PubMed ID: 9400037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term course of epilepsy in a large cohort of intellectually disabled patients.
    Huber B; Hauser I; Horstmann V; Jokeit G; Liem S; May T; Meinert T; Robertson E; Schorlemmer H; Wagner W; Seidel M
    Seizure; 2007 Jan; 16(1):35-42. PubMed ID: 17157535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine as adjunctive therapy in patients with refractory epilepsy and mental retardation.
    McKee JR; Sunder TR; FineSmith R; Vuong A; Varner JA; Hammer AE; Barrett PS
    Epilepsy Behav; 2003 Aug; 4(4):386-94. PubMed ID: 12899858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate and lamotrigine in pediatric patients with refractory epilepsy: after the first year.
    Thome-Souza S; Valente KD
    Pediatr Neurol; 2013 Jun; 48(6):436-42. PubMed ID: 23668867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamotrigine in epilepsy, pregnancy and psychiatry--a drug for all seasons?
    Vajda FJ; Dodd S; Horgan D
    J Clin Neurosci; 2013 Jan; 20(1):13-6. PubMed ID: 23036173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open trial lamotrigine in the treatment of self-injurious behavior in an adolescent with profound mental retardation.
    Davanzo PA; King BH
    J Child Adolesc Psychopharmacol; 1996; 6(4):273-9. PubMed ID: 9231320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K; Wang X; Xi Z; Yan Y
    Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine use in pregnancy.
    Moore JL; Aggarwal P
    Expert Opin Pharmacother; 2012 Jun; 13(8):1213-6. PubMed ID: 22594849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-release lamotrigine in the treatment of patients with epilepsy.
    Syed TU; Sajatovic M
    Expert Opin Pharmacother; 2010 Jun; 11(9):1579-85. PubMed ID: 20482306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.